Formulating for the Future of Transplant Patient Therapy

Transplant Support

Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.

Veloxis is an international company with headquarters in Hørsholm, Denmark, and a fully owned subsidiary in Edison, New Jersey, USA.

Veloxis is committed to patient access and financial support for kidney transplant patients. Learn more about our prescription cost savings programs, click here Go to


Aug 25, 2016
Conference Call Announcing Interim Report for the Second Quarter 2016

Webcast Webcast

Conference call at 3:00 pm CEST

Please dial in 5-10 minutes prior to the start time using the number / Conference ID below. 
Confirmation Code: 4376388
UK: +44(0)20 3427 1909
US: +1646 254 3361
DK: +4532 71 16 59

Stock Information